Vericel (VCEL) Change in Acquisitions & Divestments (2010 - 2026)
Vericel (VCEL) posted Change in Acquisitions & Divestments of $11.0 million for Q2 2026, down 23.07% sequentially from $14.2 million in Q1 2026, and down 25.17% YoY from $14.6 million in Q2 2025.
Analysis
Vericel (VCEL) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Vericel has reported Change in Acquisitions & Divestments for 10 years, with the latest figure at $11.0 million in Q2 2026.
- Quarterly Change in Acquisitions & Divestments fell 25.17% year-over-year to $11.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $53.7 million (down 5.86% YoY) and the FY2025 annual result came in at $55.6 million, up 4.6% from the prior year.
- Change in Acquisitions & Divestments fell to $11.0 million in Q2 2026 per VCEL's latest filing, from $14.2 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $21.5 million in Q1 2023 and troughed at $5.0 million in Q4 2022.
- A 5-year average of $14.1 million and a median of $14.4 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments sank 79.8% in 2022, then soared 326.5% in 2023.
- Over 5 years, Change in Acquisitions & Divestments stood at $5.0 million in 2022, then jumped by 274.36% to $18.7 million in 2023, then fell by 21.28% to $14.7 million in 2024, then declined by 0.58% to $14.6 million in 2025, then dropped by 25.17% to $11.0 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $11.0 million, $14.2 million, and $14.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.96 Mn |
| Mar 31, 2026 | 14.25 Mn |
| Dec 31, 2025 | 14.65 Mn |
| Sep 30, 2025 | 13.80 Mn |
| Jun 30, 2025 | 14.65 Mn |
| Mar 31, 2025 | 12.50 Mn |
| Dec 31, 2024 | 14.74 Mn |
| Sep 30, 2024 | 15.11 Mn |
| Jun 30, 2024 | 12.19 Mn |
| Mar 31, 2024 | 11.12 Mn |
| Dec 31, 2023 | 18.72 Mn |
| Sep 30, 2023 | 18.85 Mn |
| Jun 30, 2023 | 20.54 Mn |
| Mar 31, 2023 | 21.50 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 9.60 Mn |
| Jun 30, 2022 | 21.30 Mn |
| Mar 31, 2022 | 5.04 Mn |
| Dec 31, 2021 | 13.52 Mn |
| Sep 30, 2021 | 18.26 Mn |